EX-99.2 3 aaxnq12018-supplementalres.htm EXHIBIT 99.2 Exhibit


axonhorizontala04.jpg
Operating Metrics (Unaudited)
 
2018
 
2017
 
2016
 
Q1
 
Q4
Q3
Q2
Q1
 
Q4
Q3
Q2
Q1
 
 
 
 
 
 
 
 
 
 
 
 
Axon & Evidence.com Bookings (millions)
$
97.5

 
$
71.2

$
78.0

$
81.9

$
60.1

 
$
72.5

$
57.5

$
72.0

$
52.1

Sequential % Change
37
%
 
-9
 %
-5
 %
36
%
-17
 %
 
26
%
-20
 %
38
%
17
%
 
 
 
 
 
 
 
 
 
 
 
 
Software & Sensors Annual recurring Revenue (millions) (1)
$
83.3

 
$
70.0

$
63.7

$
54.7

$
46.2

 
$
40.2

$
32.0

$
21.1

$
18.1

 
 
 
 
 
 
 
 
 
 
 
 
Future Contracted Revenue (millions) (2)
 
 
$
536.0

$
494.2

$
446.4

$
390.0

 
$
350.8

$
302.0

$
262.8

$
202.3

Sequential % Change
n/a

 
8
 %
11
 %
14
%
11
 %
 
16
%
15
 %
30
%
27
%
 
 
 
 
 
 
 
 
 
 
 
 
Software & Sensors Backlog (3)
$
570.0

 
 
 
 
 
 
 
 
 
 
Sequential % Change
n/a

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multiple Year Contract % (4)
93
%
 
97
 %
98
 %
97
%
94
 %
 
88
%
89
 %
95
%
95
%
 
 
 
 
 
 
 
 
 
 
 
 
Weapons Op Inc %
30
%
 
32
 %
30
 %
33
%
35
 %
 
36
%
38
 %
33
%
34
%
 
 
 
 
 
 
 
 
 
 
 
 
Evidence.com new seats booked
25,400

 
14,100

18,400

20,600

16,400

 
21,400

15,600

20,200

15,800

 
 
 
 
 
 
 
 
 
 
 
 
Evidence.com cumulative seats booked
226,900

 
201,500

187,400

169,000

148,400

 
132,000

110,600

95,000

74,800

 
 
 
 
 
 
 
 
 
 
 
 
(1) Monthly recurring license, integration, warranty and storage revenue annualized.
 
 
 
 
 
 
 
 
 
 
 
 
(2) Cumulative bookings for Axon and Evidence.com minus cumulative recognized revenue related solely to Axon and Evidence.com
 
(3) This metric replaces our previous disclosure of Future Contracted Revenue and represents recognized contract liabilities as well as amounts that will be invoiced and recognized in future
periods. Backlog is limited only to arrangements that meet definition of a contract under Topic 606 as of March 31, 2018.
 
 
 
 
 
 
 
 
 
 
 
 
(4) For orders booked with Evidence.com seats, the % that signed multiple year contracts.